SCHEMBL13065600

SCHEMBL13065600

CCN(CC)c1ccc2nc3c(C(=O)O)c(-c4ccccc4)c(=O)c(OC)c-3oc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
KMT2A Q03164 2/20 0.47
POLB P06746 1/20 0.47
SCP2 P22307 1/20 0.42
DHODH Q02127 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
SLC16A3 O15427 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
SLC16A1 P53985 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 3/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065602 0.93 SCP2 (0.44) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13065624 0.93 DHODH (0.42) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13065593 0.93 MEN1 (0.41) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13065604 0.93 MEN1 (0.41) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13065613 0.92 MEN1 (0.42) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13065588 0.92 MEN1 (0.41) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13065606 0.91 SCP2 (0.41) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13065608 0.90 MEN1 (0.39) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13065591 0.88 MEN1 (0.49) MEN1NPC1RAB9AKMT2APOLB
SCHEMBL13065586 0.84 SCP2 (0.44) MEN1NPC1RAB9AKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 MEN1 3364/4885NPC1 2196/4885RAB9A 2459/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 MEN1 3364/4885NPC1 2196/4885RAB9A 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.